IBT4A is a potent and highly selective irreversible inhibitor of Brutons tyrosine kinase (BTK), exhibiting an IC50 of 0.5 nM. It is a valuable research tool for studying BTK-dependent signaling pathways in both cellular and animal models of B-cell malignancies and autoimmune disorders.
Molekulargewicht:
303.32
Reinheit:
99.80% (May vary between batches)
CAS Nummer:
[330786-24-8]
Formel:
C17H13N5O
Target-Kategorie:
BTK
Anwendungsbeschreibung:
Solubility: DMSO:10 mg/mL (32.97 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten